TamaFlex Fast Acting

FDA Disclaimer Statement

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

General Statements: All Other Content

Feel the difference in just 5 days

FDA Statement of Identity

Dietary Supplement

Suggested/Recommended/Usage/Directions

Directions: As a dietary supplement, take one capsule in the morning and one in the evening.

Precautions re: Pregnant or Nursing or Prescription Medications

Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Precautions re: All Other

Discontinue use two weeks prior to surgery.

Precautions re: Children

Keep out of reach of children.

Storage

Store in a cool, dry place.

Brand IP Statement(s) re: (c), (TM), (SM)

TamaFlex is a trademark of NXT USA, Inc. Patents Pending. ApresFlex is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas-Laila Nutraceuticals LLC. U.S. Patent #8,551,496 and other patents pending.

General Statements: All Other Content

In a randomized, double-blind study, 67 adults took 50 mg of ApresFlex or a placebo twice daily. Those taking ApresFlex had improvements in joint stiffness, comfort and function (WOMAC) that were 5,7 and 43 times greater vs. the placebo group after 30 days. Improvements were seen as early as 5 days.